Extracellular matrix and its therapeutic potential for cancer treatment

Huang, Jiacheng, Zhang, Lele, Wan, Dalong, Zhou, Lin, Zheng, Shusen, Lin, Shengzhang, Qiao, Yiting·2021·Signal Transduction and Targeted Therapy

Cites (588)

Items 201–400 of 588

  1. Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia
    Michael H. Tomasson, Zhifu Xiang, Richard A. Walgren, Yu Zhao, Yumi Kasai, Tracie L. Miner, Rhonda E. Ries, Olga Lubman, Daved H. Fremont, Michael D. McLellan et al. · 2008 · Blood
  2. Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions?
    Christopher A. Maxwell, James B. McCarthy, Eva Ann Turley · 2008 · Journal of Cell Science
  3. Inactivation of the Hippo tumour suppressor pathway by integrin-linked kinase
    Isabel Serrano, Paul C. McDonald, Frances E. Lock, William J. Muller, Shoukat Dedhar · 2013 · Nature Communications
  4. Mesenchymal Stem Cells Enhance Angiogenesis in Mechanically Viable Prevascularized Tissues via Early Matrix Metalloproteinase Upregulation
    Cyrus Michael Ghajar, Katherine S. Blevins, Christopher C.W. Hughes, Steven C. George, Andrew J. Putnam · 2006 · Tissue Engineering
  5. Targeting the Tumor Microenvironment in Cancer: Why Hyaluronidase Deserves a Second Look
    Clifford J. Whatcott, Haiyong Han, Richard G. Posner, Galen H. Hostetter, Daniel D. Von Hoff · 2011 · Cancer Discovery
  6. β1 Integrin Inhibition Dramatically Enhances Radiotherapy Efficacy in Human Breast Cancer Xenografts
    Park, Catherine C., Zhang, Hui J., Yao, Evelyn S., Park, Chong J., Bissell, Mina J. · 2008 · Cancer Research
  7. Hyaluronan Constitutively Regulates ErbB2 Phosphorylation and Signaling Complex Formation in Carcinoma Cells
    Shibnath Ghatak, Suniti Misra, Bryan P. Toole · 2005 · Journal of Biological Chemistry
  8. Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases
    Ritva Heljäsvaara, Pia Nyberg, Jani Luostarinen, Mataleena Parikka, Pia Heikkilä, Marko Rehn, Timo A. Sorsa, Tuula Anneli Salo, Taina A. Pihlajaniemi · 2005 · Experimental Cell Research
  9. Imaging transforming growth factor-β signaling dynamics and therapeutic response in breast cancer bone metastasis
    Manav Korpal, Jun Yan, Xin Lü, Shuwa Xu, Dorothy A. Lerit, Yibin Kang · 2009 · Nature Medicine
  10. Dependence on the Motif YIPP for the Physical Association of Jak2 Kinase with the Intracellular Carboxyl Tail of the Angiotensin II AT1 Receptor
    Mohammad Ali, Peter P. Sayeski, L B Dirksen · 1997 · Journal of Biological Chemistry
  11. CD44s Regulates the TGF-β–Mediated Mesenchymal Phenotype and Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma
    Kosuke Mima, Hirohisa Okabe, Takatsugu Ishimoto et al. · 2012 · Cancer Research
  12. VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis
    Lukas J.A.C. Hawinkels, Kim Zuidwijk, Hein W. Verspaget, Eveline S. M. de Jonge‐Muller, Wim van Duijn, Valérie Ferreira, Ruud D. Fontijn, Guido David, Daniël W. Hommes, C. B. H. W. Lamers et al. · 2008 · European Journal of Cancer
  13. RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses
    Michael W. Schmitt, Anita Schmitt, Markus Rojewski, Jinfei Chen, Krzysztof Giannopoulos, Fei Fei, Yingzhe Yu, Marlies Götz, Marta Heyduk, Gerd Ritter et al. · 2007 · Blood
  14. The Extra-domain A of Fibronectin Is a Vascular Marker of Solid Tumors and Metastases
    Jascha‐N. Rybak, Christoph Roesli, Manuela Kaspar, Alessandra Villa, Dario Neri · 2007 · Cancer Research
  15. Higher matrix stiffness as an independent initiator triggers epithelial-mesenchymal transition and facilitates HCC metastasis
    Yinying Dong, Qiongdan Zheng, Zhiming Wang, Xiahui Lin, Yang You, Sifan Wu, Yaohui Wang, Chao Hu, Xiaoying Xie, Jie Chen et al. · 2019 · Journal of Hematology & Oncology
  16. Expression of human hyaluronan synthases in response to external stimuli
    Annica Jacobson, Jonas W. Brinck, Michael Briskin, Andrew P. Spicer, Paraskevi Heldin · 2000 · Biochemical Journal
  17. The Hyaluronan Receptor RHAMM Regulates Extracellular-regulated Kinase
    Shiwen Zhang, Michael C.Y. Chang, Danuta Zylka, Stefanie Turley, Rene E. Harrison, Eva Ann Turley · 1998 · Journal of Biological Chemistry
  18. Aging-associated modifications of collagen affect its degradation by matrix metalloproteinases
    Preety Panwar, Georgina S. Butler, Andrew Jamroz, Pouya Azizi, Christopher M. Overall, Dieter Brömme · 2017 · Matrix Biology
  19. The emergence of integrins: a personal and historical perspective
    Richard O. Hynes · 2004 · Matrix Biology
  20. Overexpression of the Cell Adhesion Molecules DDR1, Claudin 3, and Ep-CAM in Metaplastic Ovarian Epithelium and Ovarian Cancer
    Viola A Heinzelmann-Schwarz, Margaret Gardiner‐Garden, Susan M. Henshall, James Scurry, Richard A. Scolyer, Michael J. Davies, Matthias Heinzelmann, Larry Hilton Kalish, Anish Bali, James G. Kench et al. · 2004 · Clinical Cancer Research
  21. Expression of tumor-associated antigens in acute myeloid leukemia: implications for specific immunotherapeutic approaches
    Jochen Greiner, Michael W. Schmitt, Li Li, Krzysztof Giannopoulos, Katrin Bosch, Anita Schmitt, Konstanze Döhner, Richard F. Schlenk, Jonathan R. Pollack, Hartmut Döhner et al. · 2006 · Blood
  22. CD44v8-10 Is a Cancer-Specific Marker for Gastric Cancer Stem Cells
    Wen Min Lau, Eileen Teng, Hui Shan Chong · 2014 · Cancer Research
  23. LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates
    James W. Purcell, Sonia G. Tanlimco, Jonathan A. Hickson, Melvin Fox, Mien Sho, Lisa M. Durkin, Tamar Uziel, Rick Powers, Kelly Foster, Thomas P. McGonigal et al. · 2018 · Cancer Research
  24. Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer
    Y. Funada, Tsuyoshi Noguchi, 隆一 菊池 · 2003 · Oncology Reports
  25. Inhibition of αvβ3 Integrin Survival Signaling Enhances Antiangiogenic and Antitumor Effects of Radiotherapy
    Amir Abdollahi, David W. Griggs, Heike Zieher, Alexandra K. Roth, Kenneth E. Lipson, Rainer Saffrich, Hermann‐Josef Gröne, Dennis E. Hallahan, Ralph A. Reisfeld, Jürgen Debus et al. · 2005 · Clinical Cancer Research
  26. Force Engages Vinculin and Promotes Tumor Progression by Enhancing PI3K Activation of Phosphatidylinositol (3,4,5)-Triphosphate
    Matthew G. Rubashkin, Luke Cassereau, Russell O. Bainer, Christopher C. DuFort, Yoshihiro Yui, Guanqing Ou, Matthew J. Paszek, Michael W. Davidson, Yunn‐Yi Chen, Valerie Marie Weaver · 2014 · Cancer Research
  27. Molecular interactions between chondroitin–dermatan sulfate and growth factors/receptors/matrix proteins
    Shuji Mizumoto, Shuhei Yamada, Kazuyuki Sugahara · 2015 · Current Opinion in Structural Biology
  28. Epidermal Growth Factor Activates Hyaluronan Synthase 2 in Epidermal Keratinocytes and Increases Pericellular and Intracellular Hyaluronan
    Juha-Pekka Pienimäki, Kirsi J. Rilla, Csaba Fülöp · 2001 · Journal of Biological Chemistry
  29. Chondroitin sulphate: a focus on osteoarthritis
    Mamta Bishnoi, Ankit Jain, Pooja Hurkat, Sanjay Jain · 2016 · Glycoconjugate Journal
  30. Nuclear lamin stiffness is a barrier to 3D-migration, but softness can limit survival
    Takamasa Harada, Joe Swift, Jerome Irianto · 2014 · Northeast Bioengineering Conference
  31. RHAMM Is a Centrosomal Protein That Interacts with Dynein and Maintains Spindle Pole Stability
    Christopher A. Maxwell, Jonathan J. Keats, Mary Crainie, Xuejun Sun, Tim J. Yen, Ellen K. Shibuya, Michael J. Hendzel, Gordon K. T. Chan, Linda M. Pilarski · 2003 · Molecular Biology of the Cell
  32. Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer
    Christopher A. Maxwell, Javier Benítez, Laia Gómez‐Baldó, Ana Osório, Núria Bonifaci, Ricardo Fernández‐Ramires, Sylvain V. Costes, Elisabet Guinó, Helen Chen, D. Gareth Evans et al. · 2011 · PLoS Biology
  33. SB-431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma cell line proliferation and motility.
    Mark D. Hjelmeland, Anita B. Hjelmeland, Sith Sathornsumetee, Elizabeth Danielle Reese, Michael H. Herbstreith, Nicholas J. Laping, Henry S. Friedman, Darell D. Bigner, Xiao-Fan Wang, Jeremy N. Rich · 2004 · PubMed
  34. Fibronectin on circulating extracellular vesicles as a liquid biopsy to detect breast cancer
    Pyong‐Gon Moon, Jeong‐Eun Lee, Young‐Eun Cho, Soo Jung Lee, Yee Soo Chae, Jin Hyang Jung, In-San Kim, Ho Yong Park, Moon‐Chang Baek · 2016 · Oncotarget
  35. A Peptide Selected by Biopanning Identifies the Integrin αvβ6 as a Prognostic Biomarker for Nonsmall Cell Lung Cancer
    Anissa N. Elayadi, Kausar N. Samli, Ludmila Prudkin, Ying-Horng Liu, Aihua Bian, Xian‐Jin Xie, Ignacio Ivan Wistuba, Jack A. Roth, Michael J. McGuire, Kathlynn C. Brown · 2007 · Cancer Research
  36. Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor.
    Hiroji Uemura, Hitoshi Ishiguro, Noboru Nakaigawa · 2003 · PubMed
  37. Nomenclature of hyaluronic acid
    Endre A. Balazs, Torvard C. Laurent, Roger W. Jeanloz · 1986 · Biochemical Journal
  38. Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion
    Qingli Shen, Vito Rosario Cicinnati, Xiaoyong Zhang, Speranţa Iacob, Frank Weber, Georgios Charalambos Sotiropoulos, Arnold Radtke, Mengji Lu, Andreas Paul, Guido Gerken et al. · 2010 · Molecular Cancer
  39. Integrins in wound healing, fibrosis and tumor stroma: High potential targets for therapeutics and drug delivery
    Jonas Schnittert, Ruchi Bansal, Gert Storm, Jai Prakash · 2018 · Advanced Drug Delivery Reviews
  40. Inhibition of Pulmonary and Skeletal Metastasis by a Transforming Growth Factor-β Type I Receptor Kinase Inhibitor
    Abhik M. Bandyopadhyay, Joseph K. Agyin, Long Wang, Yuping Tang, Xiufen Lei, Beryl M. Story, John E. Cornell, Bradley H. Pollock, Gregory R. Mundy, Lu‐Zhe Sun · 2006 · Cancer Research
  41. Spatial and molecular organization of lymph node T cell cortex: a labyrinthine cavity bounded by an epithelium-like monolayer of fibroblastic reticular cells anchored to basement membrane-like extracellular matrix
    Eric Peter Kaldjian, J. Elizabeth Gretz, Arthur O. Anderson, Yinghui Shi, Stephen Shaw · 2001 · International Immunology
  42. Pirfenidone normalizes the tumor microenvironment to improve chemotherapy
    Christiana Polydorou, Fotios Mpekris, Panagiotis Papageorgis, Chrysovalantis Voutouri, Triantafyllos Stylianopoulos · 2017 · Oncotarget
  43. The intracellular hyaluronan receptor RHAMM/IHABP interacts with microtubules and actin filaments
    Volker Assmann, David Jenkinson, John F. Marshall, Ian R. Hart · 1999 · Journal of Cell Science
  44. The tumour-targeting human L19-IL2 immunocytokine: Preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma
    Manfred Johannsen, Gianluca Spitaleri, Giuseppe Curigliano, Jan Roigas, Steffen Weikert, Carsten Kempkensteffen, Andreas P. Roemer, Christian Kloeters, Patrik Rogalla, Gabriele Pecher et al. · 2010 · European Journal of Cancer
  45. Stiffness of tumours measured by shear-wave elastography correlated with subtypes of breast cancer
    Jung Min Chang, In Ae Park, Su Hyun Lee · 2013 · European Radiology
  46. Keratinocyte Growth Factor Stimulates Migration and Hyaluronan Synthesis in the Epidermis by Activation of Keratinocyte Hyaluronan Synthases 2 and 3
    Susanna Karvinen, Sanna Pasonen‐Seppänen, Juha M. T. Hyttinen, Juha-Pekka Pienimäki, Kari Törrönen, Tiina A. Jokela, Markku Tammi, Raija Tammi · 2003 · Journal of Biological Chemistry
  47. CD44+/CD24− ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival
    Erhong Meng, B.J. Long, Paula Sullivan, Steve McClellan, Michael A. Finan, Eddie Reed, Lalita A. Shevde, Rodney Paul Rocconi · 2012 · Clinical & Experimental Metastasis
  48. Ki26894, a novel transforming growth factor‐β type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line
    Shogo Ehata, Aki Hanyu, Μakoto Fujime, Yoko Katsuno, Erina Fukunaga, Kouichiro Goto, Yuichi Ishikawa, Kimie Nomura, Hiroshi Yokoo, Toshiyuki Shimizu et al. · 2006 · Cancer Science
  49. A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer
    Katherine M. Bell‐McGuinn, Carolyn M. Matthews, Steffan N. Ho, Minal A. Barve, Lucy Gilbert, Richard T. Penson, Ernst R. Lengyel, Rameshraja Palaparthy, Kye M. Gilder, Artemios B. Vassos et al. · 2011 · Gynecologic Oncology
  50. The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression.
    Chao Wang, Ann D. Thor, Dan H. Moore · 1998 · PubMed
  51. Induction of cardiac fibroblast lysyl oxidase by TGF-β1 requires PI3K/Akt, Smad3, and MAPK signaling
    Tetyana G Voloshenyuk, Elizabeth S. Landesman, Elena Khoutorova, Andrew D. Hart, Jason D. Gardner · 2011 · Cytokine
  52. Overexpression of the αvβ6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival
    Suzanne Hazelbag, Gemma G. Kenter, Arko Gorter, EJ Dreef, LA Koopman, SM Violette, Paul H. Weinreb, G.J. Fleuren · 2007 · The Journal of Pathology
  53. Collagen types. Molecular structure and tissue distribution.
    Robert E. Burgeson, Marcel E. Nimni · 1992 · PubMed
  54. SB-431542, a small molecule transforming growth factor-β-receptor antagonist, inhibits human glioma cell line proliferation and motility
    Mark D. Hjelmeland, Anita B. Hjelmeland, Sith Sathornsumetee, Elizabeth Danielle Reese, Michael H. Herbstreith, Nicholas J. Laping, Henry S. Friedman, Darell D. Bigner, Xiao‐Fan Wang, Jeremy N. Rich · 2004 · Molecular Cancer Therapeutics
  55. Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma
    Chiara Ambrogio, Gonzalo Goméz-López, Mattia Falcone, August Vidal, Ernest Nadal, Nicola Crosetto, Rafael B Blasco, Pablo J. Fernández-Marcos, Montse Sánchez‐Céspedes, Xiaomei Ren et al. · 2016 · Nature Medicine
  56. FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia
    R. Angelo de Claro, Karen M. McGinn, Nicole C. Verdun, Shwu‐Luan Lee, Haw-Jyh Chiu, Haleh Saber, Margaret E. Brower, Chai‐Ni Chang, Elimika Pfuma Fletcher, Bahru A. Habtemariam et al. · 2015 · Clinical Cancer Research
  57. Fibronectin splice variants: understanding their multiple roles in health and disease using engineered mouse models
    White, Eric S., Muro, Andrés F. · 2011 · IUBMB Life
  58. Hyaluronan Constitutively Regulates Activation of Multiple Receptor Tyrosine Kinases in Epithelial and Carcinoma Cells
    Suniti Misra, Bryan P. Toole, Shibnath Ghatak · 2006 · Journal of Biological Chemistry
  59. Direct reprogramming of stem cell properties in colon cancer cells by CD44
    Ying-Jhen Su, Hsin‐Mei Lai, Yi‐Wen Chang, Guan‐Ying Chen, Jia-Lin Lee · 2011 · The EMBO Journal
  60. Rhamm−/− fibroblasts are defective in CD44-mediated ERK1,2 motogenic signaling, leading to defective skin wound repair
    Cornelia Tölg, Sara R. Hamilton, Kerry‐Ann Nakrieko, Fatemeh Kooshesh, Paul A. Walton, James B. McCarthy, Mina J. Bissell, Eva Ann Turley · 2006 · The Journal of Cell Biology
  61. Expression of the oncofetal ED-B–containing fibronectin isoform in hematologic tumors enables ED-B–targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patients
    Stefanie Sauer, Paola Anna Erba, Mario Petrini, Andreas Menrad, Leonardo Giovannoni, Chiara Grana, Burkhard Hirsch, Luciano Zardi, Giovanni Paganelli, Giuliano Mariani et al. · 2009 · Blood
  62. Glypican-3 binds to frizzled and plays a direct role in the stimulation of canonical Wnt signaling
    Mariana Capurro, Tonya L. Martin, Wen Shi, Jorge Filmus · 2014 · Journal of Cell Science
  63. EGF Upregulates, Whereas TGF-β Downregulates, the Hyaluronan Synthases Has2 and Has3 in Organotypic Keratinocyte Cultures: Correlations with Epidermal Proliferation and Differentiation
    Sanna Pasonen‐Seppänen, Susanna Karvinen, Kari Törrönen, Juha M. T. Hyttinen, Tiina A. Jokela, Mikko Juhani Lammi, Markku Tammi, Raija Tammi · 2003 · Journal of Investigative Dermatology
  64. Laminins: Roles and Utility in Wound Repair
    Iorio, Valentina, Troughton, Lee D., Hamill, Kevin J. · 2015 · Advances in Wound Care
  65. High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer
    P. Lipponen, Sirpa H. Aaltomaa, Raija Tammi, Markku Tammi, Ulla M. Ågren, Veli‐Matti Kosma · 2001 · European Journal of Cancer
  66. Discovery and Optimization of 3-(2-(Pyrazolo[1,5-a]pyrimidin-6-yl)ethynyl)benzamides as Novel Selective and Orally Bioavailable Discoidin Domain Receptor 1 (DDR1) Inhibitors
    Mingshan Gao, Lei Duan, Jinfeng Luo, Lianwen Zhang, Xiaoyun Lu, Yan Zhang, Zhang Zhang, Zhengchao Tu, Yong Xu, Xiaomei Ren et al. · 2013 · Journal of Medicinal Chemistry
  67. Inhibition of Rspo-Lgr4 Facilitates Checkpoint Blockade Therapy by Switching Macrophage Polarization
    Binghe Tan, Xiujuan Shi, Jie Zhang, Juliang Qin, Na Zhang, Hua Ren, Min Qian, Stefan K. Siwko, Kendra S. Carmon, Qingyun Liu et al. · 2018 · Cancer Research
  68. Therapeutic Applications of Glycosaminoglycans
    Nicola Volpi · 2006 · Current Medicinal Chemistry
  69. Antibody Against CD44s Inhibits Pancreatic Tumor Initiation and Postradiation Recurrence in Mice
    Ling Li, Xinbao Hao, Jun Qin et al. · 2014 · Gastroenterology
  70. Volociximab, a Chimeric Monoclonal Antibody that Specifically Binds α5β1 Integrin: A Phase I, Pharmacokinetic, and Biological Correlative Study
    Alejandro Daniel Ricart, Anthony W. Tolcher, Glenn Liu · 2008 · Clinical Cancer Research
  71. Ibrutinib: First Global Approval
    Fiona Cameron, Mark Sanford · 2014 · Drugs
  72. Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis
    Gavin Tjin, Eric S. White, Alen Faiz, Delphine Sicard, Daniel J. Tschumperlin, Annabelle M. Mahar, Eleanor Kable, Janette Kay Burgess · 2017 · Disease Models & Mechanisms
  73. Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate
    Leena P. Setälä, Markku Tammi, Raija Tammi, Matti J. Eskelinen, P. Lipponen, Ulla M. Ågren, Jyrki J. Parkkinen, E. M. ALHAVA, V‐M Kosma · 1999 · British Journal of Cancer
  74. CD44 variant 6 is associated with prostate cancer metastasis and chemo‐/radioresistance
    Jie Ni, Paul J. Cozzi, Jing Hao et al. · 2014 · The Prostate
  75. NAB-Paclitaxel Improves Disease-Free Survival in Early Breast Cancer: GBG 69–GeparSepto
    Michael Untch, Christian Jackisch, Andreas Schneeweiß et al. · 2019 · Journal of Clinical Oncology
  76. β1-integrin-mediated signaling essentially contributes to cell survival after radiation-induced genotoxic injury
    Nils Cordes, Johanna Franziska Seidler, Rita Durzok, Hans Geinitz, Cord Brakebusch · 2005 · Oncogene
  77. αvβ6 integrin in wound healing and cancer of the oral cavity
    Gareth J. Thomas, Maria L. Nystrom, John F. Marshall · 2005 · Journal of Oral Pathology and Medicine
  78. Tumor-extracellular matrix interactions: Identification of tools associated with breast cancer progression
    Marta Giussani, Giuseppe Merlino, Vera Cappelletti, Elda Tagliabue, Maria Grazia Daidone · 2015 · Seminars in Cancer Biology
  79. HALO-109–301: a Phase III trial of PEGPH20 (with Pemcitabine and Nab-Paclitaxel) in Hyaluronic Acid-High Stage IV Pancreatic Cancer
    Gary Joseph Doherty, Margaret A. Tempero, Pippa G. Corrie · 2017 · Future Oncology
  80. Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory T cells
    Paul L. Bollyky, Ben A. Falk, Rebecca P. Wu, Jane Hoyt Buckner, Thomas N. Wight, Gerald T. Nepom · 2009 · Journal of Leukocyte Biology
  81. Engineering Stimuli‐Activatable Boolean Logic Prodrug Nanoparticles for Combination Cancer Immunotherapy
    Bo Hou, Lei Zhou, Hui Wang, Madiha Saeed, Dangge Wang, Zhiai Xu, Yaping Li, Haijun Yu · 2020 · Advanced Materials
  82. Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via α9β1 integrin
    Smita Kale, Remya Raja, D Thorat · 2013 · Oncogene
  83. A Novel Mode for Integrin-mediated Signaling: Tethering Is Required for Phosphorylation of FAK Y397
    Qi Shi, David Boettiger · 2003 · Molecular Biology of the Cell
  84. Molecular Cloning of Human Fibroblast Hyaluronic Acid-binding Protein Confirms Its Identity with P-32, a Protein Co-purified with Splicing Factor SF2
    Tushar Baran Deb, Kasturi Datta · 1996 · Journal of Biological Chemistry
  85. Inhibition of Collagen Receptor Discoidin Domain Receptor-1 (DDR1) Reduces Cell Survival, Homing, and Colonization in Lung Cancer Bone Metastasis
    Karmele Valencia, Cristina Ormazabal, Carolina Zandueta, Diego Luis-Ravelo, Iker Antón, Maria Jose Pajares, Jackeline Agorreta, Luis M. Montuenga, Susana Martínez-Canarias, Birgit Leitinger et al. · 2012 · Clinical Cancer Research
  86. CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis
    Roberta Lugano, Kalyani Vemuri, Di Yu, Michael Bergqvist, Anja Smits, Magnus Essand, Staffan Johansson, Elisabetta Dejana, Anna Dimberg · 2018 · Journal of Clinical Investigation
  87. Fibronectin at Select Sites Binds Multiple Growth Factors and Enhances their Activity: Expansion of the Collaborative ECM-GF Paradigm
    Jia X. Zhu, Richard A.F. Clark · 2013 · Journal of Investigative Dermatology
  88. Phage antibodies with pan-species recognition of the oncofoetal angiogenesis marker fibronectin ED-B domain
    Barbara Carnemolla, Dario Neri, Patrizia Castellani, Alessandra Leprini, Giovanni Neri, Alessandro Pini, Greg P. Winter, Luciano Zardi · 1996 · International Journal of Cancer
  89. Substrate Specificity of αvβ3Integrin-mediated Cell Migration and Phosphatidylinositol 3-Kinase/AKT Pathway Activation
    Duo-Qi Zheng, Amy S. Woodard, Giovanni Tallini, Lucia Raffaella Languino · 2000 · Journal of Biological Chemistry
  90. Chronic myeloid leukemia: 2012 update on diagnosis, monitoring, and management
    Elias Joseph Jabbour, Hagop M. Kantarjian · 2012 · American Journal of Hematology
  91. A Dose-Escalation and Signal-Generating Study of the Immunocytokine L19-IL2 in Combination with Dacarbazine for the Therapy of Patients with Metastatic Melanoma
    Thomas Eigentler, Benjamin Weide, Filippo de Braud, Gianluca Spitaleri, Antonella Romanini, Annette Pflugfelder, Reinerio González‐Iglesias, Annaelisa Tasciotti, Leonardo Giovannoni, Kathrin Schwager et al. · 2011 · Clinical Cancer Research
  92. Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma
    Caroline Elizabeth Ford, Susan Abdullah Lau, Chang‐Qi Zhu, Tommy Andersson, Ming‐Sound Tsao, Wolfgang F. Vogel · 2007 · British Journal of Cancer
  93. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.
    Shigeo Matsuyama, Manabu Iwadate, Miki Kondo, Masao Saitoh, Aki Hanyu, Kiyoshí Shimizu, Hiroyuki Aburatani, Hiromu K. Mishima, Takeshi Imamura, Kohei Miyazono et al. · 2003 · PubMed
  94. Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages
    João Incio, Priya Suboj, Shan M. Chin, Trupti Vardam-Kaur, Hao Liu, Tai Hato, Suboj Babykutty, Ivy X. Chen, Vikram Deshpande, Rakesh K. Jain et al. · 2015 · PLoS ONE
  95. Digesting a Path Forward: The Utility of Collagenase Tumor Treatment for Improved Drug Delivery
    Aaron Dolor, Francis C. Szoka · 2018 · Molecular Pharmaceutics
  96. Hyaluronate Receptors Mediating Glioma Cell Migration and Proliferation
    Yasuhiko Akiyama, Shin Jung, Bodour Salhia, Sangpyung Lee, Sherri-Lynn Hubbard, Michael D. Taylor, Todd G. Mainprize, Kotaro Akaishi, Wouter R. van Furth, James T. Rutka · 2001 · Journal of Neuro-Oncology
  97. Proliferation centres in B‐cell malignant lymphoma, lymphocytic (B‐CLL): an immunophenotypic study
    Christoph Schmid, P G Isaacson · 1994 · Histopathology
  98. Tranilast-induced stress alleviation in solid tumors improves the efficacy of chemo- and nanotherapeutics in a size-independent manner
    Panagiotis Papageorgis, Christiana Polydorou, Fotios Mpekris, Chrysovalantis Voutouri, Eliana A. Agathokleous, Constantina P. Kapnissi‐Christodoulou, Triantafyllos Stylianopoulos · 2017 · Scientific Reports
  99. Type I, II, III, IV, V, and VI Collagens Serve as Extracellular Ligands for the Isoforms of Platelet-derived Growth Factor (AA, BB, and AB)
    Rajan Somasundaram, Detlef Schuppan · 1996 · Journal of Biological Chemistry
  100. An unusual N-terminal deletion of the laminin 3a isoform leads to the chronic granulation tissue disorder laryngo-onycho-cutaneous syndrome
    W.H. Irwin McLean · 2003 · Human Molecular Genetics
  101. CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma.
    Robert Alfred Clark, Ronen Alon, Timothy A. Springer · 1996 · The Journal of Cell Biology
  102. Dexamethasone Increases Cisplatin-Loaded Nanocarrier Delivery and Efficacy in Metastatic Breast Cancer by Normalizing the Tumor Microenvironment
    John D. Martin, Myrofora Panagi, Chenyu Wang, Thahomina Khan, Margaret R. Martin, Chrysovalantis Voutouri, Kazuko Toh, Panagiotis Papageorgis, Fotios Mpekris, Christiana Polydorou et al. · 2019 · ACS Nano
  103. Hyaluronan–CD44 Interaction Promotes Oncogenic Signaling, microRNA Functions, Chemoresistance, and Radiation Resistance in Cancer Stem Cells Leading to Tumor Progression
    Lilly Bourguignon, Marisa Shiina, Jian Jian Li · 2014 · Advances in cancer research
  104. Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indicates poor prognosis for hepatocellular carcinoma
    Zheng‐Jun Zhou, Zhi Dai, Shao‐Lai Zhou, Xiutao Fu, Yiming Zhao, Ying–Hong Shi, Jian Zhou, Jia Fan · 2012 · International Journal of Cancer
  105. CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence
    Kenro Hirata, Hidekazu Suzuki, Hiroyuki Imaeda · 2013 · British Journal of Cancer
  106. Role of fibronectin assembly in platelet thrombus formation
    Jaehyung Cho, Deane F. Mosher · 2006 · Journal of Thrombosis and Haemostasis
  107. Targeting transforming growth factor-β signaling in liver metastasis of colon cancer
    Bixiang Zhang, Sunil K. Halder, Sanguo Zhang, Pran K. Datta · 2009 · Cancer Letters
  108. Real-Time Imaging of Resident T Cells in Human Lung and Ovarian Carcinomas Reveals How Different Tumor Microenvironments Control T Lymphocyte Migration
    H. Bougherara, A. Mansuet-Lupo, M. Alifano, C. Ngô, D. Damotte, M. Le Frère-Belda, E. Donnadieu, E. Peranzoni · 2015 · Frontiers in Immunology
  109. Changes in the expression of αv integrins in oral squamous cell carcinomas
    Judith K. Jones, Fiona M. Watt, Paul Michael Speight · 1997 · Journal of Oral Pathology and Medicine
  110. Extracellular Matrix Density Regulates the Rate of Neovessel Growth and Branching in Sprouting Angiogenesis
    Lowell T. Edgar, Clayton J. Underwood, James Guilkey, James B. Hoying, Jeffrey A. Weiss · 2014 · PLoS ONE
  111. Role of the Sulfation Pattern of Chondroitin Sulfate in its Biological Activities and in the Binding of Growth Factors
    C. Nandini, Kazuyuki Sugahara · 2006 · Advances in pharmacology
  112. Collagen Types
    Robert E. Burgeson, Marcel E. Nimni · 1992 · Clinical Orthopaedics and Related Research
  113. The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells
    Volker Assmann, John F. Marshall, Christina Fieber · 1998 · Journal of Cell Science
  114. The First Stage of Transforming Growth Factor β1 Activation is Release of the Large Latent Complex from the Extracellular Matrix of Growth Plate Chondrocytes by Matrix Vesicle Stromelysin-1 (MMP-3)
    Shingo Maeda, David D. Dean, R. Gómez, Zvi Schwartz, Barbara D. Boyan · 2002 · Calcified Tissue International
  115. Overexpression of Protein Tyrosine Kinases in Human Esophageal Cancer
    Tetsuo Nemoto, Kenichi Ohashi, Takumi Akashi · 2008 · Pathobiology
  116. A RHAMM mimetic peptide blocks hyaluronan signaling and reduces inflammation and fibrogenesis in excisional skin wounds.
    C. Tolg, Sara R. Hamilton, Ewa Zalinska, L. McCulloch, Ripal P Amin, N. Akentieva, F. Winnik, R. Savani, D. Bägli, L. Luyt et al. · 2012 · American Journal of Pathology
  117. Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma
    Christoph Renné, Klaus Willenbrock, Ralf Küppers, Martin‐Leo Hansmann, Andreas Bräuninger · 2005 · Blood
  118. Molecular markers of endometrial carcinoma detected in uterine aspirates
    Eva Colás, Cristina Perez, Sílvia Cabrera et al. · 2011 · International Journal of Cancer
  119. Discoidin Domain Receptor-1a (DDR1a) Promotes Glioma Cell Invasion and Adhesion in Association with Matrix Metalloproteinase-2
    Rosalyn R. Ram, Gustavo Lorente, Karoly Nikolich, Roman Urfer, Erik D. Foehr, Usha Nagavarapu · 2005 · Journal of Neuro-Oncology
  120. The inclusion of the type III repeat ED-B in the fibronectin molecule generates conformational modifications that unmask a cryptic sequence.
    Barbara Carnemolla, Alessandra Leprini, Giorgio Allemanni, Marco Saginati, Luciano Zardi · 1992 · Journal of Biological Chemistry
  121. Immunohistochemical screening for β6‐integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up‐regulation in pancreatic ductal adenocarcinomas in vivo and in vitro
    Bence Sipos, Diane Hahn, A Carceller, Jaume Piulats, J. Hedderich, Holger Kalthoff, Simon L. Goodman, Markus Kosmahl, Günter Klöppel · 2004 · Histopathology
  122. Inhibition of Mammary Tumor Growth Using Lysyl Oxidase-Targeting Nanoparticles to Modify Extracellular Matrix
    Mathumai Kanapathipillai, Akiko Mammoto, Tadanori Mammoto, Joo Hee Kang, Elisabeth Jiang, Kaustabh Ghosh, Netanel Korin, Ashley D. Gibbs, Robert J. Mannix, Donald E. Ingber · 2012 · Nano Letters
  123. Nuclear constriction segregates mobile nuclear proteins away from chromatin
    Jerome Irianto, Charlotte R. Pfeifer, Rachel R. Bennett, Yuntao Xia, Irena Lambrova Ivanovska, Andrea J. Liu, Roger A. Greenberg, Dennis E. Discher · 2016 · Molecular Biology of the Cell
  124. Immunoregulatory properties of CD44+ cancer stem‐like cells in squamous cell carcinoma of the head and neck
    Kazuaki Chikamatsu, Goro Takahashi, Koichi Sakakura, Soldano Ferrone, Keisuke Masuyama · 2010 · Head & Neck
  125. Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma
    Oscar G. Arrieta, P Guevara, E Escobar · 2005 · British Journal of Cancer
  126. β1 integrin–dependent Rac/group I PAK signaling mediates YAP activation of Yes-associated protein 1 (YAP1) via NF2/merlin
    Hiba Sabra, Molly Brunner, Vinay Mandati, Bernhard Wehrle‐Haller, Dominique Lallemand, Anne‐Sophie Ribba, Geneviève Chevalier, Philippe Guardiola, Marc R. Block, Daniel Bouvard · 2017 · Journal of Biological Chemistry
  127. Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma
    Vaibhav Sahai, Paul J. Catalano, Mark M. Zalupski, Sam Joseph Lubner, Mark R. Menge, Halla Sayed Nimeiri, Hidayatullah G. Munshi, Al B. Benson, Peter James O'Dwyer · 2018 · JAMA Oncology
  128. Angiotensin II Potentiates Vascular Endothelial Growth Factor-Induced Proliferation and Network Formation of Endothelial Progenitor Cells
    Toshio Imanishi, Takuzo Hano, Ichiro Nishio · 2004 · Hypertension Research
  129. Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer
    Ganesh S. Palapattu, Chengyu Wu, Christopher R. Silvers, Heather B. Martin, Karin Williams, Linda Salamone, Timothy P. Bushnell, Li‐Shan Huang, Qi Yang, Jiaoti Huang · 2009 · The Prostate
  130. The microRNA miR-34a Inhibits Non-Small Cell Lung Cancer (NSCLC) Growth and the CD44hi Stem-Like NSCLC Cells
    Yang Shi, Can Liu, Xin Liu · 2014 · PLoS ONE
  131. TGF-β and cancer
    Michael Reiß · 1999 · Microbes and Infection
  132. Inhibition of discoidin domain Receptor 1 reduces collagen-mediated tumorigenicity in pancreatic ductal adenocarcinoma
    Aguilera, Kristina Y., Huang, Huocong, Du, Wenting, Hagopian, Moriah M., Wang, Zhen, Hinz, Stefan, Hwang, Tae Hyun, Wang, Huamin, Fleming, Jason B., Castrillon, Diego H. et al. · 2017 · Molecular Cancer Therapeutics
  133. Matrix stiffness and tumor-associated macrophages modulate epithelial to mesenchymal transition of human adenocarcinoma cells
    Marta Alonso‐Nocelo, Theresa M. Raimondo, Kyle H. Vining, Rafael López‐López, María de la Fuente, David J. Mooney · 2018 · Biofabrication
  134. Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells
    Simona Greco, Antonella Muscella, Maria Giovanna Elia · 2003 · Journal of Cellular Physiology
  135. Dynamic structure of plasma fibronectin
    Lisa M. Maurer, Wenjiang Ma, Deane F. Mosher · 2016 · Critical Reviews in Biochemistry and Molecular Biology
  136. Activation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1
    Yair Herishanu, Federica Gibellini, Ndegwa Njuguna, Inbal Hazan‐Halevy, Mohammed Z. H. Farooqui, Sarah Bern, Keyvan Keyvanfar, Elinor Lee, Wyndham Hopkins Wilson, Adrian U. Wiestner · 2011 · Leukemia & lymphoma/Leukemia and lymphoma
  137. Irradiation differentially affects substratum-dependent survival, adhesion, and invasion of glioblastoma cell lines
    Nils Cordes, B Hansmeier, Christina Beinke, Viktor Meineke, Dirk Van Beuningen · 2003 · British Journal of Cancer
  138. Inhibition of DDR1‐BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer
    Maya Jeitany, Cédric Leroy, Priscillia Tosti, Marie Lafitte, Jordy Le Guet, Valérie Simon, Débora Bonenfant, Bruno Robert, Fanny Grillet, Caroline Mollévi et al. · 2018 · EMBO Molecular Medicine
  139. Identification and characterization of epitopes of the receptor for hyaluronic acid–mediated motility (RHAMM/CD168) recognized by CD8+ T cells of HLA-A2–positive patients with acute myeloid leukemia
    Jochen Greiner, Li Li, Mark Ringhoffer · 2005 · Blood
  140. Regulation of PD-L1 expression by matrix stiffness in lung cancer cells
    Ayako Miyazawa, Satoru Ito, Shuichi Asano, Ichidai Tanaka, Mitsuo Sato, Masashi Kondo, Yoshinori Hasegawa · 2017 · Biochemical and Biophysical Research Communications
  141. Matrix-regulated integrin αvβ5 maintains α5β1-dependent desmoplastic traits prognostic of neoplastic recurrence
    Franco-Barraza, Janusz, Francescone, Ralph, Luong, Tiffany, Shah, Neelima, Madhani, Raj, Cukierman, Gil, Dulaimi, Essel, Devarajan, Karthik, Egleston, Brian L, Nicolas, Emmanuelle et al. · 2017 · eLife
  142. VEGF and HIF-1α expression are increased in advanced stages of epithelial ovarian cancer
    Cheung Wong, Theresa L. Wellman, Karen M. Lounsbury · 2003 · Gynecologic Oncology
  143. Cilengitide: An RGD Pentapeptide ανβ3 and ανβ5 Integrin Inhibitor in Development for Glioblastoma and Other Malignancies
    David A. Reardon, Bart Neyns, Michael Weller, J. C. Tonn, Burt Nabors, Roger Stupp · 2011 · Future Oncology
  144. Glycosaminoglycans modulate fibronectin matrix assembly and are essential for matrix incorporation of tenascin-C
    Chang Y. Chung, Harold Erickson · 1997 · Journal of Cell Science
  145. Integrin alphavbeta6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver
    Guang‐Yun Yang, Kesen Xu, Zhong‐Qing Pan · 2008 · Cancer Science
  146. An unusual N-terminal deletion of the laminin 3a isoform leads to the chronic granulation tissue disorder laryngo-onycho-cutaneous syndrome
    W.H. Irwin McLean · 2003 · Human Molecular Genetics
  147. α v β 6 Integrin-A Marker for the Malignant Potential of Epithelial Ovarian Cancer
    Nuzhat Ahmed, Clyde B. Riley, Gregory Edward Rice · 2002 · Journal of Histochemistry & Cytochemistry
  148. A Phase 1 Study of AS1409, a Novel Antibody-Cytokine Fusion Protein, in Patients with Malignant Melanoma or Renal Cell Carcinoma
    Sarah Maria Rudman, Michael B. Jameson, Mark James McKeage · 2011 · Clinical Cancer Research
  149. Radioimmunotherapy of Solid Tumors by Targeting Extra Domain B Fibronectin: Identification of the Best-Suited Radioimmunoconjugate
    Dietmar Berndorff, Sandra Borkowski, Stephanie Sieger, Axel Rother, Matthias Friebe, Francesca Viti, Christoph Stephan Hilger, John E. Cyr, Ludger M. Dinkelborg · 2005 · Clinical Cancer Research
  150. Cross-Talk Between the Tumor Microenvironment, Extracellular Matrix, and Cell Metabolism in Cancer
    Mona Nazemi, Elena Rainero · 2020 · Frontiers in Oncology
  151. Elevated hyaluronan concentration without hyaluronidase activation in malignant epithelial ovarian tumors.
    Essi L J Hiltunen, Maarit A. Anttila, Anne H. Kultti et al. · 2002 · PubMed
  152. Induction of the Stem-like Cell Regulator CD44 by Rho Kinase Inhibition Contributes to the Maintenance of Colon Cancer–Initiating Cells
    Hirokazu Ohata, Tatsuya Ishiguro, Yuki Aihara, Ai Sato, Hiroaki Sakai, Shigeki Sekine, Hirokazu Taniguchi, Takayuki Akasu, Shin Fujita, Hitoshi Nakagama et al. · 2012 · Cancer Research
  153. Angiotensin II Induces Migration and Pyk2/Paxillin Phosphorylation of Human Monocytes
    Ulrich Kintscher, Shu Wakino, Sarah Kim, Eckart Fleck, Willa A. Hsueh, Ronald E. Law · 2001 · Hypertension
  154. Human pancreatic tumor cells are sensitized to ionizing radiation by knockdown of caveolin-1
    Nils Cordes, S Frick, Thomas Baptist Brunner · 2007 · Oncogene
  155. Recent progress and applications in glycosaminoglycan and heparin research
    Tatiana N. Laremore, Fuming Zhang, Jonathan S. Dordick · 2009 · Current Opinion in Chemical Biology
  156. Tumor-expressed collagens can modulate immune cell function through the inhibitory collagen receptor LAIR-1
    Tomasz P. Rygiel, Ellen H. Stolte, Talitha Eshuis-de Ruiter, Michael L. van de Weijer, Linde Meyaard · 2011 · Molecular Immunology
  157. Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung carcinomas
    Moon · 2010 · Oncology Reports
  158. Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature.
    Bernard M. Tijink, Dario Neri, Charles René Leemans · 2006 · PubMed
  159. Structural Mechanisms Determining Inhibition of the Collagen Receptor DDR1 by Selective and Multi-Targeted Type II Kinase Inhibitors
    Peter Canning, Li Tan, Kiki Chu, Sam W. Lee, Nathanael S. Gray, Alex N. Bullock · 2014 · Journal of Molecular Biology
  160. Regulation of the proteolytic disintegrin metalloproteinases, the ‘Sheddases’
    Gillian Murphy · 2008 · Seminars in Cell and Developmental Biology
  161. Mutation rate of normal and malignant human lymphocytes.
    R. S. Seshadri, Robert Kutlaca, K Trainor · 1987 · PubMed
  162. Hyaluronic acid-based extracellular matrix triggers spontaneous M2-like polarity of monocyte/macrophage
    Hyebin Kim, Junghwa Cha, Minjeong Jang, Pilnam Kim · 2019 · Biomaterials Science
  163. Integrin ανβ6 Acts as a Prognostic Indicator in Gastric Carcinoma
    Zong‐Li Zhang, K.-S. Xu, J.-S. Wang · 2007 · Clinical Oncology
  164. Targeting chronic lymphocytic leukemia cells with a humanized monoclonal antibody specific for CD44
    Suping Zhang, Christina C. N. Wu, Jessie-F. Fecteau et al. · 2013 · Proceedings of the National Academy of Sciences
  165. Coexpression of CD44‐positive/CD133‐positive cancer stem cells and CD204‐positive tumor‐associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma
    Ya‐Chin Hou, Ying‐Jui Chao, Hui‐Ling Tung · 2014 · Cancer
  166. A Novel Glycosaminoglycan-binding Protein Is the Vertebrate Homologue of the Cell Cycle Control Protein, Cdc37
    Nicholas Grammatikakis, Aliki Grammatikakis, Masahiko Yoneda, Qin Yu, Shib D. Banerjee, Bryan P. Toole · 1995 · Journal of Biological Chemistry
  167. Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia
    Norbert Vey, Jacques Delaunay, Giovanni Martinelli, Walter Fiedler, Emmanuel Raffoux, Thomas Prébet, Carlos Gomez‐Roca, Cristina Papayannidis, Maxim Kebenko, Peter Paschka et al. · 2016 · Oncotarget
  168. Ibrutinib (PCI-32765), the First BTK (Bruton’s Tyrosine Kinase) Inhibitor in Clinical Trials
    Jennifer R. Brown · 2013 · Current Hematologic Malignancy Reports
  169. Prostate cancer antigen‐1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer
    Keiji Shimada, Mitsutoshi Nakamura, Eiwa Ishida, Tomonori Higuchi, Hiroshi Yamamoto, Kazutake Tsujikawa, Noboru Konishi · 2007 · Cancer Science
  170. Angiotensin II Induces Expression of the Tie2 Receptor Ligand, Angiopoietin-2, in Bovine Retinal Endothelial Cells
    Atsushi Otani, Hitoshi Takagi, Hideyasu Oh, Shinji Koyama, Yoshihito Honda · 2001 · Diabetes
  171. Hormonal regulation of cardiac fibroblast function
    Christian G. Brilla, B Maisch, Guoping Zhou · 1995 · European Heart Journal
  172. Expression patterns of the novel receptor-like tyrosine kinase, DDR, in human breast tumours.
    K T Barker, J E Martindale, Mitchell Pj, Tahereh Kamalati, Page Mj, David J. Phippard, Trevor C. Dale, Gusterson Ba, M R Crompton · 1995 · PubMed
  173. Clinical significance and biological role of cancer‐derived Type I collagen in lung and esophageal cancers
    Shuo Fang, Yongdong Dai, Yan Mei, Mingming Yang, Liang Hu, Hong Yang, Xininyuan Guan, Jiangchao Li · 2019 · Thoracic Cancer
  174. Collagen fiber structure guides 3D motility of cytotoxic T lymphocytes
    Hawley C. Pruitt, Daniel M. Lewis, Mark Ciccaglione, Sydney C Connor, Quinton Smith, John W. Hickey, Jonathan P. Schneck, Sharon Gerecht · 2019 · Matrix Biology
  175. Localization of hyaluronate and hyaluronate-binding protein on motile and non-motile fibroblasts
    Eva Ann Turley, J. Torrance · 1985 · Experimental Cell Research
  176. Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2
    Teresa Mercade Macarulla, Roberto Pazo-Cid, Carmen Guillén‐Ponce, Rafael López‐López, Ruth Vera, Margarita Reboredo, Andrés Jesús Muñoz Martín, Fernando Rivera, Roberto Díaz Beveridge, Adelaida La Casta et al. · 2018 · Journal of Clinical Oncology
  177. Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: relevance with tumor progression.
    Huilin Li, Lingchuan Guo, J W Li · 2000 · International Journal of Oncology
  178. Potential Role for Hyaluronan and the Hyaluronan Receptor RHAMM in Mobilization and Trafficking of Hematopoietic Progenitor Cells
    Linda M. Pilarski, Eva Pruski, Juanita Wizniak, Darlene Paine, Karen L. Seeberger, Michael J. Mant, Christopher B. Brown, Andrew R. Belch · 1999 · Blood
  179. Inhibitory effect of a TGFβ receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells
    Osamu Shinto, Masakazu Yashiro, Hidemi Kawajiri, K. Shimizu, Toshiyuki Shimizu, Atsushi Miwa, Kosei Hirakawa · 2010 · British Journal of Cancer
  180. PEG-PLA nanoparticles modified with APTEDB peptide for enhanced anti-angiogenic and anti-glioma therapy
    Guangzhi Gu, Quanyin Hu, Xingye Feng · 2014 · Biomaterials
  181. Altered Microenvironment Promotes Progression of Preinvasive Breast Cancer: Myoepithelial Expression of αvβ6 Integrin in DCIS Identifies High-risk Patients and Predicts Recurrence
    Michael D. Allen, Gareth J. Thomas, Sarah J. Clark, Marwa Mohammed Dawoud, Sabarinath Vallath, Sarah JL Payne, Jennifer J. Gomm, Sally A. Dreger, Sarah Dickinson, Dylan R. Edwards et al. · 2013 · Clinical Cancer Research
  182. CD44: A Cancer Stem Cell–Related Biomarker with Predictive Potential for Radiotherapy
    Michael A. Baumann, Mechthild Krause · 2010 · Clinical Cancer Research
  183. GIT1 Functions as a Scaffold for MEK1–Extracellular Signal-Regulated Kinase 1 and 2 Activation by Angiotensin II and Epidermal Growth Factor
    Guoyong Yin, Judith Haendeler, Yan Chen, Bradford C. Berk · 2003 · Molecular and Cellular Biology
  184. Expression and function of a receptor for hyaluronan-mediated motility on normal and malignant B lymphocytes
    EA Turley, AJ Belch, Sibrand Poppema · 1993 · Blood
  185. Delivery of CD44 shRNA/Nanoparticles within Cancer Cells
    Suniti Misra, Vincent Hascall, Carla De Giovanni, Roger R. Markwald, Shibnath Ghatak · 2009 · Journal of Biological Chemistry
  186. Prognostic value of the expression of Ki‐67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma
    E. Yıldız, Gökhan Gökçe, Hakan Kılıçarslan · 2004 · British Journal of Urology
  187. Cilengitide (EMD 121974) arrests the growth of a heavily pretreated highly vascularised head and neck tumour
    Jan-Dirk Raguse, Hans Joachim Gath, Jürgen Bier, Hanno B. Riess, Helmut Oettle · 2003 · Oral Oncology
  188. Improving the distribution of Doxil® in the tumor matrix by depletion of tumor hyaluronan
    Aditya G. Kohli, Saul Kivimäe, Matthew R. Tiffany, Francis C. Szoka · 2014 · Journal of Controlled Release
  189. Transforming growth factor β signaling pathway: A promising therapeutic target for cancer
    Yuhong Chen, Cuixia Di, Xuetian Zhang, Jing Wang, Fang Wang, Jun‐fang Yan, Caipeng Xu, Jinhua Zhang, Qianjing Zhang, Hongyan Li et al. · 2019 · Journal of Cellular Physiology
  190. RHAMM (CD168) is overexpressed at the protein level and may constitute an immunogenic antigen in advanced prostate cancer disease.
    K. Gust, M. Hofer, S. Perner, R. Kim, A. Chinnaiyan, S. Varambally, P. Møller, L. Rinnab, M. Rubin, J. Greiner et al. · 2009 · Neoplasia
  191. GIT1 Mediates Src-dependent Activation of Phospholipase Cγ by Angiotensin II and Epidermal Growth Factor
    Judith Haendeler, Guoyong Yin, Yukihiro Hojo · 2003 · Journal of Biological Chemistry
  192. Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung cancer and promotes cell invasion via epithelial-to-mesenchymal transition
    Liyun Miao, Suhua Zhu, Yongsheng Wang, Yan Li, Jingjing Ding, Jinghong Dai, Hourong Cai, Deping Zhang, Yong Song · 2013 · Medical Oncology
  193. Hyaluronan‐CD44/RHAMM interaction‐dependent cell proliferation and survival in lung cancer cells
    Jung Min Song, Jintaek Im, Richard Seonghun Nho, Yong Hwan Han, Pramod Upadhyaya, Fekadu Kassie · 2018 · Molecular Carcinogenesis
  194. Ionizing radiation induces up-regulation of functional β 1-integrin in human lung tumour cell lines in vitro
    Nils Cordes, Marcel Bläse, Viktor Meineke, Dirk Van Beuningen · 2002 · International Journal of Radiation Biology
  195. Differences between Squamous Cell Carcinoma and Keratoacanthoma in Angiotensin Type-1 Receptor Expression
    Hikaru Takeda, Shigeo Kondo · 2001 · American Journal Of Pathology
  196. Equibiaxial cyclic stretch stimulates fibroblasts to rapidly remodel fibrin
    Jenna Leigh Balestrini, Kristen Lawrence Billiar · 2006 · Journal of Biomechanics
  197. Molecular Characterization of a Novel Intracellular Hyaluronan-binding Protein
    Lei Huang, Nicholas Grammatikakis, Masahiko Yoneda, Shib D. Banerjee, Bryan P. Toole · 2000 · Journal of Biological Chemistry
  198. Growth stimulatory angiotensin II type-1 receptor is upregulated in breast hyperplasia and in situ carcinoma but not in invasive carcinoma
    Boél De Paepe, Valerie L. R. M. Verstraeten, C. R. De Potter · 2001 · Histochemistry and Cell Biology
  199. Expression of fibronectin variants in vascular and visceral smooth muscle cells in development
    Marina A. Glukhova, Maria G. Frid, Boris V. Shekhonin, Yury V. Balabanov, Victor Koteliansky · 1990 · Developmental Biology
  200. CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer
    Seiya Saito, HIROHISA OKABE, Masayuki Watanabe, Takatsugu Ishimoto, Masaaki Iwatsuki, Yoshifumi Baba, Youhei Tanaka, Junji Kurashige, Yuji Miyamoto, Hideo Baba · 2013 · Oncology Reports